Filing Details
- Accession Number:
- 0001104659-18-003365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-22 20:41:30
- Reporting Period:
- 2018-01-18
- Accepted Time:
- 2018-01-22 20:41:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267813 | Marinus Pharmaceuticals Inc | MRNS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615437 | Michael Christopher Cashman | C/O Marinus Pharmaceuticals 170 N Radnor Chester Rd Suite 250 Radnor PA 19087 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-18 | 9,566 | $6.28 | 247,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of common stock in order to satisfy tax withholding obligations upon vesting of restricted stock.
Billionaire Hedge Funds
